Sceletium Tortuosum.
A South African succulent (kanna) that lifts mood and eases anxiety, traditionally used for centuries by indigenous peoples. Acts as a natural serotonin reuptake inhibitor and PDE4 inhibitor, boosting mood, reducing anxiety, and improving cognitive flexibility under stress.
Reviewed March 2026
- Category
- Herb
- Also filed under
- Reduces anxiety and stressImproves mood noticeablyEnhances cognitive flexibility under stress
What Sceletium Tortuosum is, and what it does.
- Does it work
- Centuries of traditional use backed by modern clinical trials. The mood and anxiety effects are noticeable, not subtle. Quality matters enormously though.
- How much to take
- 25 mg of standardized extract (like Zembrin) per day. Raw plant powder requires much higher doses (100-200 mg). Sublingual delivery hits faster.
- Time to feel it
- The first dose lands inside 30 to 60 minutes as a gentle easing of anxious thinking. The steadier baseline builds across one to two weeks.
- The first dose
- You can feel this on the first dose. A gentle mood lift and reduction in anxious thinking within 30-60 minutes. Not dramatic like a drug, but clearly noticeable.
- With regular use
- Effects may build over 1-2 weeks of daily use. Some people report improved emotional resilience and stress tolerance with ongoing supplementation.
- How well tolerated
- Generally well tolerated, but do NOT combine with SSRIs, SNRIs, or MAOIs. The serotonergic activity can stack dangerously. If you're on antidepressants, this is off limits.
- How it feels
- Calm and present. Like your baseline anxiety drops a few notches. Good for social situations, stressful work, or just taking the edge off a rough day.
- The overlooked benefit
- The traditional fermentation step is not folklore. It shifts the ratio of mesembrine to mesembrenone, so fermented and unfermented material are not the same alkaloid mix.
25 to 50mg a day is where Sceletium Tortuosum works.
Source: Terburg et al., 2013; Harvey et al., 2011
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Reduces anxiety measurably
- Improves cognitive flexibility under stress
- Acts as a natural SSRI
Questions people ask about Sceletium Tortuosum.
- Can I take this with my antidepressant?
- No. Kanna acts on serotonin similarly to SSRIs. Combining them risks serotonin syndrome, which can be dangerous. Talk to your doctor before mixing any serotonergic substances.
- Will I build tolerance?
- Some users report mild tolerance with daily use over months. Taking weekends off or cycling 5 days on, 2 off can help maintain sensitivity.
- Is this legal?
- Yes in most countries, including the US and EU. It's banned in a few places (Louisiana in the US has restrictions). Check your local regulations.
- How is Zembrin different from raw kanna?
- Zembrin is standardized to specific mesembrine alkaloid content and is the form used in clinical trials. Raw kanna powder varies wildly in potency. You might get a strong batch or basically nothing.
- Is sublingual really faster?
- Yes. Sublingual absorption bypasses your digestive system and liver. Effects can start in 15-20 minutes vs. 45-60 minutes for capsules. The taste is bitter though.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Mesembrine acts as a serotonin reuptake inhibitor while 5-HTP raises serotonin synthesis directly. Loading the precursor while blocking reuptake stacks on one neurotransmitter system and is a combination to keep apart.
The same molecule as 5-HTP feeds serotonin synthesis while sceletium alkaloids slow serotonin clearance from the synapse. Combining a precursor with a reuptake inhibitor is additive on serotonergic signalling.
Tryptophan is the upstream substrate for serotonin synthesis, and sceletium slows reuptake of what is made. The two push the same pathway from supply and clearance ends at once.
Hyperforin broadly inhibits monoamine reuptake including serotonin, the same synaptic action attributed to mesembrine. Two reuptake inhibitors in one formula are additive rather than complementary.
Saffron crocins and safranal are reported to act on serotonergic signalling, the same system sceletium alkaloids work on. The overlap means the effects add rather than cover separate ground.
Sceletium alkaloids inhibit phosphodiesterase-4, raising cyclic AMP, while caffeine blocks adenosine receptors and also weakly inhibits phosphodiesterase. The two converge on raised cyclic AMP tone, so jitteriness appears at lower doses of each.
L-theanine raises alpha-band activity and moderates glutamate release, a route unrelated to serotonin reuptake. Formulas use it to keep the alerting side of sceletium from tipping into edginess.
Withanolides act on cortisol and the stress axis rather than on synaptic monoamines. Pairing them addresses two separate layers of the same felt state without overlapping receptor targets.
Serotonin is made from 5-hydroxytryptophan by aromatic L-amino acid decarboxylase, and that enzyme requires pyridoxal 5-phosphate. Sceletium alkaloids act on serotonin handling rather than on its synthesis, so adequate B6 supports the supply side of the same system. This is settled cofactor biochemistry and needs no combination trial. It is a supporting nutrient relationship, not an amplification claim.
Pyridoxal 5-phosphate is the coenzyme form used directly by aromatic L-amino acid decarboxylase in monoamine synthesis. Supplying it alongside a serotonergic botanical addresses the cofactor requirement of the synthesis step. The relationship is textbook enzymology. It says nothing about how much any given product changes serotonin levels.
Magnesium participates as a cofactor in ATP-dependent steps throughout neurotransmitter synthesis and is a standard component of formulas aimed at supporting a calm state. Sceletium contributes alkaloids acting on serotonin transport and phosphodiesterase activity. The two work through different points and are combined for coverage. No trial of the pair was identified.
Magnolia bark honokiol and magnolol act at GABA-A sites while Sceletium alkaloids act on serotonin transport, so the two arrive at a similar felt effect by different routes. That is exactly why they appear together in evening blends, and it is also the reason the combination can be more sedating than either alone. Users adding a second calming ingredient should account for the additive effect. No controlled study of the pair was identified.
Passionflower is used for the same evening and calm-state purpose and acts largely through GABAergic routes. Combining it with a serotonergic botanical raises the total calming load without either ingredient being dose-adjusted. That is a caution worth stating rather than a benefit worth claiming. Nothing measured the combination.
Valerian acts through GABAergic mechanisms and is one of the more sedating botanicals in common use. Adding it to a Sceletium product stacks two different calming routes in the same dose. The practical consequence is more drowsiness than either produces alone, which matters for driving and for machinery. This row exists as a caution, not a recommendation.
Rhodiola is used to support mental performance during periods of demand and Sceletium is used for cognitive flexibility under load, so blends combine them. Rhodiola also has monoamine oxidase inhibitory activity in vitro, which means a stack of two monoamine-active botanicals deserves a conservative dose. No combination study was identified. The interaction concern is more concrete than the benefit rationale.
Bacopa is a slow-acting cognitive-support botanical whose effects in trials build over weeks, while Sceletium is used acutely. Blends pair them for a fast and slow combination. The mechanisms do not overlap. Nothing measures the pair.
Tyrosine is the precursor for dopamine and noradrenaline, and its supplementation is studied for maintaining performance under acute stress. Sceletium alkaloids have reported activity at the serotonin transporter and at phosphodiesterase 4. Pairing them addresses two different monoamine branches. The precursor step is established biochemistry. The joint effect is untested.
GABA is added to calm-focused blends alongside serotonergic botanicals as a matter of formulation habit. Orally administered GABA crosses the blood-brain barrier poorly, so how much of any felt effect is central remains contested. The pairing is convention rather than a demonstrated interaction. State the absorption caveat wherever the pair appears.
Melatonin is synthesised from serotonin by N-acetylation and O-methylation, so the two sit on the same biosynthetic line. In an evening product the combination stacks a sedating hormone with a serotonin-directed botanical. The biosynthetic relationship is established. The combined effect on sleep has not been measured. The additive drowsiness is the practical point.
Talk to a doctor before taking Sceletium Tortuosum if any of these apply to you: Don't combine with SSRIs or MAOIs (serotonin risk), Quality varies hugely between products. These are flags to check first, not effects Sceletium Tortuosum is known to cause.
Not medical advice. Show the label to your pharmacist.What Sceletium Tortuosum actually does.
Phosphodiesterase 4 breaks down cyclic AMP, a messenger molecule inside cells, so slowing that enzyme lets the message run louder and longer.
Your body builds serotonin from tryptophan in two steps, and the final step depends on an enzyme that runs on pyridoxal 5-phosphate, an active vitamin cofactor.
Melatonin is made from serotonin in two further chemical steps, so anything aimed at serotonin sits upstream of the melatonin pathway too.
In cell studies, mesembrine, the plant's main alkaloid, blocks the serotonin transporter, and mesembrenone slows an enzyme called phosphodiesterase 4. That pairing is the activity most often described for this plant.
Where Sceletium Tortuosum comes from.
The succulent is harvested and, in the traditional method, sealed and left to ferment for several days before drying, which changes the mix of its active alkaloids. Modern makers extract the dried plant with water or alcohol and measure the alkaloid content of each batch.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
A succulent native to the Karoo region of South Africa, now largely cultivated. Harvest is regulated and material is subject to South African access and benefit-sharing rules
Crushed plant material is held in a sealed container for several days, which shifts the relative proportions of the mesembrine-type alkaloids before drying
Modern grades extract the dried material with water or ethanol to concentrate the alkaloid fraction. Some producers skip the fermentation step entirely
The liquor is filtered and reduced under vacuum, with the alkaloid fraction carried through rather than isolated as a single compound
Grades are declared either as a total alkaloid percentage or as a defined ratio of mesembrine, mesembrenone, mesembrenol and mesembranol
Spray- or vacuum-dried onto a carrier, milled and blended to a uniform assay before encapsulation
Getting Sceletium Tortuosum from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In recreationally trained adults, eight days of Sceletium tortuosum was compared with placebo on mood, visual tracking and reaction measures, and any differences were confined to part of the test battery rather than seen across it.Randomised trial. Hoffman et al., 2020 (Journal of strength and conditioning research). PMID 32740286 ↗
- The review summarises the traditional use, alkaloid chemistry and modern research on Sceletium and concludes that the human clinical evidence base remains small and preliminary.Narrative review. Brendler T et al., 2021 (Current Neuropharmacology). PMID 33588735 ↗
- A bibliometric analysis maps the phytochemical and pharmacological research on Sceletium and identifies where the published activity is concentrated and where it is thin.Narrative review. Reddy K et al., 2024 (Frontiers in Plant Science). PMID 38576783 ↗
- A standardised Sceletium tortuosum extract altered immune signalling markers in the cell systems tested.In vitro study. Bennett AC et al., 2018 (Journal of Ethnopharmacology). PMID 29253615 ↗
These are the studies our verdict leans on, chosen from the 6 we read for Sceletium Tortuosum. The full linked list is below.
The studies, linked.
1 source behind our Sceletium Tortuosum verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialPsychological Effects of 8 Weeks Supplementation With Sceletium Tortuosum Extract (Zembrin™): a Randomised, Double Blind, Placebo-controlled, Parallel-groups TrialClinicalTrials.gov ↗120 participants, Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
